[HTML][HTML] Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management
S Boussios, G Pentheroudakis, K Katsanos… - Annals of …, 2012 - ncbi.nlm.nih.gov
The toxicity of cancer chemotherapy is among the most important factors limiting its use.
Clear delineation and communication of benefits and risks is an essential component of …
Clear delineation and communication of benefits and risks is an essential component of …
Chemotherapy induced gastrointestinal toxicities
HI Akbarali, KH Muchhala, DK Jessup… - Advances in cancer …, 2022 - Elsevier
Chemotherapy—induced gastrointestinal dysfunction is a common occurrence associated
with many different classes of chemotherapeutic agents. Gastrointestinal toxicity includes …
with many different classes of chemotherapeutic agents. Gastrointestinal toxicity includes …
Gastrointestinal toxicity of chemotherapeutic agents
EP Mitchell - Seminars in Oncology, 2006 - Elsevier
Chemotherapy-induced toxicities commonly occur in sites within the gastrointestinal (GI)
tract and account for dose-limiting effects. These toxicities are major contributing factors to …
tract and account for dose-limiting effects. These toxicities are major contributing factors to …
Acute and long-term gastrointestinal consequences of chemotherapy
F Di Fiore, E Van Cutsem - Best Practice & Research Clinical …, 2009 - Elsevier
There are many anti-neoplastic agents in cancer treatment. Combination regimens are often
the main standard treatment, particularly for gastrointestinal malignancies. The introduction …
the main standard treatment, particularly for gastrointestinal malignancies. The introduction …
Gastrointestinal complications of oncologic therapy
M Davila, RS Bresalier - Nature Clinical Practice Gastroenterology & …, 2008 - nature.com
Gastrointestinal complications are common in patients undergoing various forms of cancer
treatment, including chemotherapy, radiation therapy, and molecular-targeted therapies …
treatment, including chemotherapy, radiation therapy, and molecular-targeted therapies …
Regimen-related gastrointestinal toxicities in cancer patients
ST Sonis - Current opinion in supportive and palliative care, 2010 - journals.lww.com
Mucosal injury induced by radiation or chemotherapy is a common, painful, function
disrupting toxicity that, currently, has limited treatment options. The evolving understanding …
disrupting toxicity that, currently, has limited treatment options. The evolving understanding …
Gastrointestinal side effects of cancer treatments
M O'Reilly, G Mellotte, B Ryan… - … Advances in Chronic …, 2020 - journals.sagepub.com
Cancer survival rates have significantly improved over the last number of years due to
advancements in cancer therapies. Unfortunately this has come at a cost. Therapeutic side …
advancements in cancer therapies. Unfortunately this has come at a cost. Therapeutic side …
[HTML][HTML] Treatment-related gastrointestinal toxicities and advanced colorectal or pancreatic cancer: A critical update
G Aprile, K Rihawi, E De Carlo… - World journal of …, 2015 - ncbi.nlm.nih.gov
Gastrointestinal toxicities (GIT), including oral mucositis, nausea and vomiting, and diarrhea,
are common side effects of chemotherapy and targeted agents in patients with advanced …
are common side effects of chemotherapy and targeted agents in patients with advanced …
Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer
FGA Jansman, DT Sleijfer, JC de Graaf, JLLM Coenen… - Drug Safety, 2001 - Springer
The anticancer agents fluorouracil, raltitrexed, irinotecan and oxaliplatin show limited
efficacy in the treatment of colorectal cancer and may be associated with substantial toxicity …
efficacy in the treatment of colorectal cancer and may be associated with substantial toxicity …
Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer
C Eng - Nature Reviews Clinical Oncology, 2009 - nature.com
Among the many chemotherapeutic options for metastatic colorectal cancer, none has
shown clear superiority in efficacy. All pharmacologic agents in current use have been …
shown clear superiority in efficacy. All pharmacologic agents in current use have been …